GM-CSF as successful salvage therapy of metamizole (dipyrone)-induced agranulocytosis with Fournier's gangrene and severe septic shock in an adolescent
- PMID: 27525093
- PMCID: PMC4974437
- DOI: 10.1002/ccr3.616
GM-CSF as successful salvage therapy of metamizole (dipyrone)-induced agranulocytosis with Fournier's gangrene and severe septic shock in an adolescent
Abstract
This case report describes the successful use of granulocyte and macrophage colony-stimulating factor as salvage therapy and an alternative to hematopoietic stem cell transplantation in a 14-year-old adolescent with metamizole (dipyrone)-induced agranulocytosis and severe septic shock.
Keywords: Agranulocytosis; filgrastim; metamizole (dipyrone); sargramostim; septic shock.
Figures


References
-
- Andrès, E. , Maloisel F., and Zimmer J.. 2010. The role of haematopoietic growth factors granulocyte colony‐stimulating factor and granulocyte‐macrophage colony‐stimulating factor in the management of drug‐induced agranulocytosis. Br. J. Haematol. 150:3–8. - PubMed
-
- Product instruction Novalgin® (metamizole), product instruction service GermanyAvailable at http://www.fachinfo.de/suche/fi/014708. Published May 2014, (accessed April 17, 2015).
-
- Beauchesne, M.‐F. , and Shalansky S. J.. 1999. Nonchemotherapy drug‐induced agranulocytosis: a review of 118 patients treated with colony‐stimulating factors. Pharmacotherapy 19:299–305. - PubMed
-
- Garbe, E. 2007. Non‐chemotherapy drug‐induced agranulocytosis. Expert. Opin. Drug Saf. 6:323–335. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources